PROGRAM
WELCOME RECEPTION – NH CASA SUECIA ROOFTOP
Welcome Reception sponsored by:
20:30 – 21:00: Registration – You can pick up your delegate badge here!
21:00 – 21:15: Welcome remarks:
Ion Arocena, Asebio Managing Director
Juan Manuel Garrido, Innovation & Institutional Relations Director, Kaudal
21:15 – 22:30: Cocktail Reception
The Welcome Reception is an invitation-only event reserved exclusively for investors, sponsors & those companies/institutions registered to the event. This event provides an unparalleled networking opportunity before the official program begins on the following day.
Casa Suecia opened in 1956 as meeting point of the Swedish community in Madrid: the ground floor accommodated the Scandinavian Center and the rest of the building would be the Hotel Suecia, in whose dining room, the Bellman, they kept alive such traditions as the spring party or the smorgasbord lunches. An emblematic space in which personalities such as Ernest Hemingway, Ernesto Che Guevara, Julio Cortázar or the Royal Swedish Family stayed.
ASEBIO INVESTOR DAY PRELIMINARY PROGRAM
-Jesús González-Nieto, Managing Director, BME-MAB
-Ion Arocena, Managing Director, ASEBIO - Spanish Bioindustry Association
Moderator:
- Irene Sanchez, Business Creation Manager, EIT Health
Speakers:
- Sylvain Sachot, Investment Director, Sabadell Asabys Health
- Daniel Oliver, Director, Capital Cell
- Carlos Taule, Consultant, Genesis Biomed
Advanced Therapies:
10:20 - 10:30 Andalusian Network of Advanced Therapies
10:30 - 10:40 Cellus Biomedica
10:40 -10:50 CNIO - National Cancer Research Centre
10:50 - 11:00 Histocell
11:00 - 11:10 Qrem
Cardiovascular:
11:10 - 11:20 Zecardio Therapeutics
Moderator: Sergio Vela, Invest in Spain
Speakers:
- Raul Martin, Principal, Ysios Capital
- Anjan Aralihalli, Venture Partner, CTI Life Sciences
- Philippe Monteyne, Partner, Fund +
Oncology:
12:40 - 12:50 Allinky Biopharma
12:50 - 13:00 Ona Therapeutics
13:00 - 13:10 Laminar Pharmaceuticals
13:10 - 13:20 Life Length
13:20 - 13:30 Nanoligent
13:30 - 13:40 Bioncotech
Recombinant Biologics:
13:40 - 13:50
Algenex
Moderator & Speaker: Antonio Gomez, Spain New Venture Lead, Johnson & Johnson Innovation
Speakers:
- Michel de Baar, Executive Director, BD&L , MSD>
- Sascha Bucher, Head Basel Roivant Pharma & Head Global Transactions , Roivant Sciences
BIOTECHNOLOGY - OTHER THERAPEUTIC AREAS
15:40 - 15:50
39ytu
15:50 - 16:00 Abvance Biotech
16:00 - 16:10 Aptatargets
16:10 - 16:20 Innoup
16:20 - 16:30 Limnopharma
16:30 - 16:40
Molomics
16:40 - 16:50 Galea Pharmaceuticals
16:50 - 17:00 Sylentis
17:00 -17:10 VLP the Vaccines Company
17:10 - 17:20 Evolgene
17:20 -17:30 Remab Therapeutics
17:30 -17:40 Neurofix Pharma
Moderator:
Jesús Gonzalez-Nieto, Managing Director, MAB - Alternative Equity Market
Speakers:
- Pilar de la Huerta, CEO, ADL Bionatur Solutions
- Jose María Roset, CEO, Biosearch Life
Public Companies:
10:20 - 10:30 ADL Bionaur
10:30 -10:40 Atrys Health
10:40 -10:50 Biosearch Life
Pre-Market Companies:
10:50 - 11:00 SOM Biotech
11:00 - 11:10 Labiana Life Sciences
11:00 - 11:10 BIOMAR
Moderator: Juan Manuel Garrido,Innovation & Institutional Relations Director, Kaudal
Speakers:
- Pilar de la Huerta, CEO, ADL Bionatur Solutions
- Ricardo Madrid, CEO & Scientific Director, Biassays
- Miguel Angel Salineros, CFO, Iberia Sandoz (Novartis Group)
- Antonio Fernández-Huerga, President, Preventiva Seguros
- Asución Martín, Tax & Legal Services Partner and Insurance Sector Manager at PwC
ASTHMA:
Eversens
Innoprick
CENTRAL NERVOUS SYSTEM:
Admit Therapeutics
Biocross
MJN Neuroserveis
ONCOLOGY:
Biomedica Molecular Medicine
Genetracer
Taby Diagnostics
Moderator & Speaker: Adrià Escolà, Tech4Health Manager, Fundacion Ship2b
Speakers:
- Isaac Chocron, Business Development Iberia, OurCrowd
- Borja Carsi, Biotechnology & Life Sciences, Growth and Innovation Finance
- Beatriz Volckaert, Impact Investment Analyst, Fundacion Ship2b
DIAGNOSTICS-MEDTECH-DIGITAL HEALTH: OTHER THERAPEUTIC AREAS
Adan Medical
Aortyx
Biel Glasses
Biohope
Ebers Medical
Elcode
Microviable Therapeutics
Droplite
Innitius
Medmesafe
Rheodx
-
REGISTRATION08:30 - 09:00
-
OFFICIAL WELCOME09:00 - 09:30
-
EARLY STAGE INVESTMENT PANELSEED/ EARLY STAGE PANEL09:40 - 10:20
-
COMPANY PRESENTATIONSBIOTECHNOLOGY - ADVANCED THERAPIES & CARDIOVASCULAR10:20 - 11:30
-
COFFEE BREAK11:30 - 12:00
-
INTERNATIONAL VENTURE CAPITAL PANEL12:00 - 12:40
-
COMPANY PRESENTATIONSBIOTECHNOLOGY: ONCOLOGY & RECOMBINANT BIOLOGICS12:40 - 14:00
-
LUNCH14:00 - 15:00
-
PHARMA BIOTECH COLLABORATIONS15:00 - 15:40
-
COMPANY PRESENTATIONSBIOTECHNOLOGY: OTHER THERAPEUTIC AREAS15:40 - 17:40
-
REGISTRATION08:30 - 09:00
-
REGISTRATION08:30 - 09:00
-
STOCK MARKETS: SMART FUNDING FOR STRONGER BUSINESS09:40 - 10:20
-
COMPANY PRESENTATIONSPUBLIC & PRE-MARKET COMPANIES10:20 - 11:30
-
COFFEE BREAK11:30 - 12:00
-
NON DILUTIVE FUNDING PANEL12:00 - 12:40
-
COMPANY PRESENTATIONSDIAGNOSTICS-MEDTECH-DIGITAL HEALTH: ASTHMA - CNS - ONCOLOGY12:40 - 14:00
-
LUNCH14:00 - 15:00
-
IMPACT INVESTMENT IN MEDTECH PANEL15:00 - 15:40
-
COMPANY PRESENTATIONSDIAGNOSTICS-MEDTECH-DIGITAL HEALTH: OTHER THERAPEUTIC AREAS15:40 - 17:40